Faecal Microbiota Transplantation as an Adjuvant Treatment for Extraintestinal Disorders: Translating Insights from Human Medicine to Veterinary Practice

Faecal microbiota transplantation (FMT) has emerged as a transformative therapy in human medicine, particularly for managing recurrent <i>Clostridioides difficile</i> infections and other gastrointestinal (GI) disorders. Beyond the GI tract, FMT has shown potential in addressing extraint...

Full description

Bibliographic Details
Published in:Veterinary Sciences
Main Authors: Alice Nishigaki, Julian R. Marchesi, Renato L. Previdelli
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Subjects:
Online Access:https://www.mdpi.com/2306-7381/12/6/541
_version_ 1849452776423161856
author Alice Nishigaki
Julian R. Marchesi
Renato L. Previdelli
author_facet Alice Nishigaki
Julian R. Marchesi
Renato L. Previdelli
author_sort Alice Nishigaki
collection DOAJ
container_title Veterinary Sciences
description Faecal microbiota transplantation (FMT) has emerged as a transformative therapy in human medicine, particularly for managing recurrent <i>Clostridioides difficile</i> infections and other gastrointestinal (GI) disorders. Beyond the GI tract, FMT has shown potential in addressing extraintestinal conditions in people, including metabolic, immune-mediated, dermatological, neurological, and infectious diseases. Research in people has highlighted its efficacy in decolonising multidrug-resistant organisms in infection, mitigating autoimmune diseases, and improving outcomes in metabolic disorders such as obesity and diabetes. Furthermore, FMT has also been linked to enhanced responses to immunotherapy in cancer and improved management of hepatic and renal conditions. These findings underscore the intricate connections between the gut microbiome and systemic health, opening novel therapeutic avenues. In veterinary medicine, while FMT has demonstrated benefits for GI disorders, its application in extraintestinal diseases remains largely unexplored. Emerging evidence suggests that conditions such as atopic dermatitis, chronic kidney disease, immune-mediated diseases, and behavioural disorders in companion animals could benefit from microbiome-targeted therapies. However, significant gaps in knowledge persist, particularly regarding the long-term safety and efficacy for veterinary applications. This review synthesises findings from human medicine to assess their relevance for veterinary applications and future research.
format Article
id doaj-art-4b4bca4ee47a4ddd8dcd54d4cd597841
institution Directory of Open Access Journals
issn 2306-7381
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
spelling doaj-art-4b4bca4ee47a4ddd8dcd54d4cd5978412025-08-20T03:26:53ZengMDPI AGVeterinary Sciences2306-73812025-06-0112654110.3390/vetsci12060541Faecal Microbiota Transplantation as an Adjuvant Treatment for Extraintestinal Disorders: Translating Insights from Human Medicine to Veterinary PracticeAlice Nishigaki0Julian R. Marchesi1Renato L. Previdelli2Department of Comparative Biomedical Sciences, Royal Veterinary College, 4 Royal College Street, London NW1 0TU, UKDivision of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College London, St. Mary’s Hospital, London W2 1NY, UKDepartment of Comparative Biomedical Sciences, Royal Veterinary College, 4 Royal College Street, London NW1 0TU, UKFaecal microbiota transplantation (FMT) has emerged as a transformative therapy in human medicine, particularly for managing recurrent <i>Clostridioides difficile</i> infections and other gastrointestinal (GI) disorders. Beyond the GI tract, FMT has shown potential in addressing extraintestinal conditions in people, including metabolic, immune-mediated, dermatological, neurological, and infectious diseases. Research in people has highlighted its efficacy in decolonising multidrug-resistant organisms in infection, mitigating autoimmune diseases, and improving outcomes in metabolic disorders such as obesity and diabetes. Furthermore, FMT has also been linked to enhanced responses to immunotherapy in cancer and improved management of hepatic and renal conditions. These findings underscore the intricate connections between the gut microbiome and systemic health, opening novel therapeutic avenues. In veterinary medicine, while FMT has demonstrated benefits for GI disorders, its application in extraintestinal diseases remains largely unexplored. Emerging evidence suggests that conditions such as atopic dermatitis, chronic kidney disease, immune-mediated diseases, and behavioural disorders in companion animals could benefit from microbiome-targeted therapies. However, significant gaps in knowledge persist, particularly regarding the long-term safety and efficacy for veterinary applications. This review synthesises findings from human medicine to assess their relevance for veterinary applications and future research.https://www.mdpi.com/2306-7381/12/6/541faecal microbiota transplantgut microbiomeveterinary medicinemicrobiome therapyextraintestinal diseasegastrointestinal disease
spellingShingle Alice Nishigaki
Julian R. Marchesi
Renato L. Previdelli
Faecal Microbiota Transplantation as an Adjuvant Treatment for Extraintestinal Disorders: Translating Insights from Human Medicine to Veterinary Practice
faecal microbiota transplant
gut microbiome
veterinary medicine
microbiome therapy
extraintestinal disease
gastrointestinal disease
title Faecal Microbiota Transplantation as an Adjuvant Treatment for Extraintestinal Disorders: Translating Insights from Human Medicine to Veterinary Practice
title_full Faecal Microbiota Transplantation as an Adjuvant Treatment for Extraintestinal Disorders: Translating Insights from Human Medicine to Veterinary Practice
title_fullStr Faecal Microbiota Transplantation as an Adjuvant Treatment for Extraintestinal Disorders: Translating Insights from Human Medicine to Veterinary Practice
title_full_unstemmed Faecal Microbiota Transplantation as an Adjuvant Treatment for Extraintestinal Disorders: Translating Insights from Human Medicine to Veterinary Practice
title_short Faecal Microbiota Transplantation as an Adjuvant Treatment for Extraintestinal Disorders: Translating Insights from Human Medicine to Veterinary Practice
title_sort faecal microbiota transplantation as an adjuvant treatment for extraintestinal disorders translating insights from human medicine to veterinary practice
topic faecal microbiota transplant
gut microbiome
veterinary medicine
microbiome therapy
extraintestinal disease
gastrointestinal disease
url https://www.mdpi.com/2306-7381/12/6/541
work_keys_str_mv AT alicenishigaki faecalmicrobiotatransplantationasanadjuvanttreatmentforextraintestinaldisorderstranslatinginsightsfromhumanmedicinetoveterinarypractice
AT julianrmarchesi faecalmicrobiotatransplantationasanadjuvanttreatmentforextraintestinaldisorderstranslatinginsightsfromhumanmedicinetoveterinarypractice
AT renatolprevidelli faecalmicrobiotatransplantationasanadjuvanttreatmentforextraintestinaldisorderstranslatinginsightsfromhumanmedicinetoveterinarypractice